Rocket One HOTH Stock
Rocket One Price Chart
Rocket One HOTH Financial and Trading Overview
| Rocket One stock price | 1.36 USD |
| Previous Close | 0 USD |
| Open | 0.87 USD |
| Bid | 1.36 USD x 200 |
| Ask | 1.47 USD x 200 |
| Day's Range | 0.75 - 1.55 USD |
| 52 Week Range | 0.49 - 2.2 USD |
| Volume | 135.37M USD |
| Avg. Volume | 7.25M USD |
| Market Cap | 26.01M USD |
| Beta (5Y Monthly) | 0.576 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HOTH Valuation Measures
| Enterprise Value | 4.05M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.915493 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.4343436 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Rocket One Stock Price History
| Beta (5Y Monthly) | 0.576 |
| 52-Week Change | 45.65% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 2.2 USD |
| 52 Week Low | 0.49 USD |
| 50-Day Moving Average | 0.76 USD |
| 200-Day Moving Average | 1.11 USD |
HOTH Share Statistics
| Avg. Volume (3 month) | 7.25M USD |
| Avg. Daily Volume (10-Days) | 30.14M USD |
| Shares Outstanding | 19.13M |
| Float | 15.79M |
| Short Ratio | 0.13 |
| % Held by Insiders | 2.89% |
| % Held by Institutions | 4.11% |
| Shares Short | 797.31K |
| Short % of Float | 4.29% |
| Short % of Shares Outstanding | 4.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -100.88% |
| Return on Equity (ttm) | -191.39% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -12469302 USD |
| Diluted EPS (ttm) | -0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.25M USD |
| Total Cash Per Share (mrq) | 0.38 USD |
| Total Debt (mrq) | 5.68K USD |
| Total Debt/Equity (mrq) | 0.09 USD |
| Current Ratio (mrq) | 4.724 |
| Book Value Per Share (mrq) | 0.396 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9803918 USD |
| Levered Free Cash Flow (ttm) | -5543313 USD |
Profile of Rocket One
| Country | United States |
| State | NJ |
| City | Hoboken |
| Address | 720 Monroe Street |
| ZIP | 07030 |
| Phone | 866 239 7459 |
| Website | https://hoththerapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. The company was incorporated in 2017 and is based in Hoboken, New Jersey.
Q&A For Rocket One Stock
What is a current HOTH stock price?
Rocket One HOTH stock price today per share is 1.36 USD.
How to purchase Rocket One stock?
You can buy HOTH shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rocket One?
The stock symbol or ticker of Rocket One is HOTH.
Which industry does the Rocket One company belong to?
The Rocket One industry is Biotechnology.
How many shares does Rocket One have in circulation?
The max supply of Rocket One shares is 19.13M.
What is Rocket One Price to Earnings Ratio (PE Ratio)?
Rocket One PE Ratio is now.
What was Rocket One earnings per share over the trailing 12 months (TTM)?
Rocket One EPS is -0.8 USD over the trailing 12 months.
Which sector does the Rocket One company belong to?
The Rocket One sector is Healthcare.
Rocket One HOTH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
| US Tech Industrial INDS | 12857.4 USD — |
-0.75
|
— — | 12813.13 USD — | 12968.45 USD — | — - | — — |
- {{ link.label }} {{link}}